Journey Medical (DERM)
(Delayed Data from NSDQ)
$5.81 USD
+0.16 (2.83%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $5.93 +0.12 (2.07%) 7:58 PM ET
5-Strong Sell of 5 5
F Value D Growth D Momentum F VGM
Journey Medical Corporation (DERM) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$9.10 | $11.00 | $8.00 | 56.63% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Journey Medical Corporation comes to $9.10. The forecasts range from a low of $8.00 to a high of $11.00. The average price target represents an increase of 56.63% from the last closing price of $5.81.
Analyst Price Targets (5 )
Broker Rating
Journey Medical Corporation currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on three recommendations.
Of the five recommendations deriving the current ABR, five are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 4 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/30/2024 | B. Riley Securities | Kalpit Patel | Strong Buy | Strong Buy |
9/6/2024 | Lake Street Capital Markets | Thomas Flaten | Not Available | Strong Buy |
8/22/2024 | Rodman & RenshawCo. | Brandon Folkes | Not Available | Strong Buy |
6/28/2024 | Roth Capital Partners | Jason Wittes | Not Available | Strong Buy |
2/16/2024 | Alliance Global Partners | Scott R Henry | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 5 |
Average Target Price | $9.10 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 93 of 252 |
Current Quarter EPS Est: | -0.17 |
DERM FAQs
Journey Medical Corporation (DERM) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for Journey Medical Corporation (DERM) is $9.10. The current on short-term price targets is based on 2 reports.
The forecasts for Journey Medical Corporation (DERM) range from a low of $8 to a high of $11. The average price target represents a increase of $56.63 from the last closing price of $5.81.
The current UPSIDE for Journey Medical Corporation (DERM) is 56.63%
Based on short-term price targets offered by five analysts, the average price target for Journey Medical Corporation comes to $9.10. The forecasts range from a low of $8.00 to a high of $11.00. The average price target represents an increase of 56.63% from the last closing price of $5.81.